Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Scand Cardiovasc J ; 53(3): 148-152, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31017007

ABSTRACT

Objectives: We aimed to investigate the outcome of tricuspid valve repair (TVR) performed concomitantly with pulmonary valve replacement in repaired tetralogy of Fallot (TOF) patients. Design: This retrospective study included all patients who underwent pulmonary vale replacement from 2000 to 2016 after TOF correction. TVR patient data were compared to those of patients who underwent pulmonary vale replacement alone. Results: Thirty-eight patients were enrolled. The degree of tricuspid regurgitation was significantly decreased after operation in the TVR group. Tricuspid valve annulus and annuloectasia before operation did not vary between groups (21.1 ± 6.3 and 41.4% in no TVR vs. 21.3 ± 4.8 and 52.6% in TVR). However pre-operative right ventricular volumes were larger in the TVR group. Normal tricuspid valve coaptation (body to body) was observed less frequently in the TVR group than in the other group (52.6% vs. 93.1%, p < .001). Pre-operative tricuspid regurgitation had a linear correlation with right ventricular volume, but not with tricuspid annulus size. Conclusion: Tricuspid annulus diameter decreased significantly regardless of TVR. Abnormal coaptations were observed more in patients group and the degree of pre-operative tricuspid regurgitation was linearly correlated with right ventricular volume rather than tricuspid annulus size.


Subject(s)
Cardiac Surgical Procedures , Heart Valve Prosthesis Implantation , Pulmonary Valve Insufficiency/surgery , Pulmonary Valve/surgery , Tetralogy of Fallot/surgery , Tricuspid Valve Insufficiency/surgery , Tricuspid Valve/surgery , Adolescent , Adult , Cardiac Surgical Procedures/adverse effects , Child , Female , Heart Valve Prosthesis Implantation/adverse effects , Humans , Male , Middle Aged , Pulmonary Valve/physiopathology , Pulmonary Valve Insufficiency/etiology , Pulmonary Valve Insufficiency/physiopathology , Recovery of Function , Retrospective Studies , Tetralogy of Fallot/complications , Tetralogy of Fallot/physiopathology , Treatment Outcome , Tricuspid Valve/physiopathology , Tricuspid Valve Insufficiency/etiology , Tricuspid Valve Insufficiency/physiopathology , Young Adult
2.
Article in English | WPRIM (Western Pacific) | ID: wpr-765005

ABSTRACT

BACKGROUND: This study aimed to determine the effect of a multidisciplinary approach on the birth rate of fetuses with prenatally diagnosed congenital heart diseases (CHDs). METHODS: Among the fetuses of 724 gravidas who underwent fetal echocardiography in Samsung Medical Center from January 2013 to June 2017, 463 fetuses with normal cardiac structure, arrhythmia or simple left-to-right shunt were excluded, and the remaining 261 were included in the study. The subjects were subdivided into groups based on whether they were consulted multidisciplinarily, that is, consulted simultaneously by pediatric cardiologists, obstetricians and pediatric cardiac surgeons or not. They were also categorized based on the initial fetal echocardiogram results. RESULTS: Among the fetuses in the multidisciplinary group, 64.5% of the fetuses were given birth to, and the proportion was not different from that in the non-multidisciplinary group (68.6%, P = 0.48). The delivery rate in the multidisciplinary consultation group were 69.2% in the transposition of the great arteries group, 63.6% in the tetralogy of Fallot group, 68.8% in the pulmonary atresia or interrupted aortic arch group, 62.5% in the coarctation of aorta group, 60.0% in the atrioventricular septal defect group, 70.0% in the functional single ventricle group, and 55.6% in the hypoplastic left heart syndrome group; there were no significant differences between the 10 echocardiogram groups. However, when the subjects were categorized into Fontan repair group and biventricular repair group, the Fontan repair group showed a significant increase in the likelihood of delivery when a multidisciplinary approach was taken (P = 0.035). CONCLUSION: When a fetus was diagnosed with a CHD where Fontan repair should be considered, a multidisciplinary approach resulted in increased possibility of delivery.


Subject(s)
Aorta, Thoracic , Aortic Coarctation , Arrhythmias, Cardiac , Arteries , Birth Rate , Echocardiography , Fetus , Heart Defects, Congenital , Heart Diseases , Hypoplastic Left Heart Syndrome , Parturition , Prenatal Diagnosis , Pulmonary Atresia , Surgeons , Tetralogy of Fallot
3.
Yonsei Medical Journal ; : 484-486, 2019.
Article in English | WPRIM (Western Pacific) | ID: wpr-742555

ABSTRACT

Infantile cortical hyperostosis, or Caffey's disease, usually presents with typical radiological features of soft tissue swelling and cortical thickening of the underlying bone. The disease can be fatal when it presents antenatally, especially before a gestational age of 35 weeks. This fatal, premature form of the disease is known to occur in various ethnic groups around the globe, and approximately 30 cases have been reported in English literature. This paper is unique in that it is the first paper to report a lethal form of prenatal-type infantile cortical hyperostosis diagnosed in South Korea. Born at gestational age of 27 weeks and 4 days, the patient had typical features of polyhydramnios, anasarca, hyperostosis of multiple bones, micrognathia, pulmonary hypoplasia, and hepatomegaly. The patient was hypotonic, and due to pulmonary hypoplasia and persistent pulmonary hypertension, had to be supported with high frequency ventilation throughout the entire hospital course. Due to the disease entity itself, as well as prolonged parenteral nutrition, liver failure progressed, and the patient expired on day 38 when uncontrolled septic shock was superimposed. The chromosome karyotype of the patient was normal, 46, XX, and COL1A1 gene mutation was not detected.


Subject(s)
Humans , Infant, Newborn , Edema , Ethnicity , Gestational Age , Hepatomegaly , High-Frequency Ventilation , Hyperostosis , Hyperostosis, Cortical, Congenital , Hypertension, Pulmonary , Infant, Premature , Karyotype , Korea , Liver Failure , Micrognathism , Parenteral Nutrition , Polyhydramnios , Shock, Septic
4.
Cancer Research and Treatment ; : 1149-1163, 2018.
Article in English | WPRIM (Western Pacific) | ID: wpr-717752

ABSTRACT

PURPOSE: Debates exist regarding the effectiveness of adjuvant chemotherapy for stage II colon cancer. This study aimed to investigate the current status of adjuvant chemotherapy and its impact on survival for Korean stage II colon cancer patients by analyzing the National Quality Assessment data. MATERIALS AND METHODS: A total of 7,880 patientswho underwent curative resection for stage II colon adenocarcinoma between January 2011 andDecember 2014 in Koreawere selected randomly as evaluation subjects for the quality assessment. The factors that influenced overall survival were identified. The high-risk group was defined as having at least one of the following: perforation/obstruction, lymph node harvest less than 12, lymphovascular/perineural invasion, positive resection margin, poor differentiation, or pathologic T4 stage. RESULTS: The median follow-up period was 38 months (range, 1 to 63 months). Chemotherapy was a favorable prognostic factor for either the high- (hazard ratio [HR], 0.76; 95% confidence interval [CI], 0.38 to 0.59; p < 0.001) or low-risk group (HR, 0.74; 95% CI, 0.61 to 0.89; p=0.002) in multivariate analysis. This was also the case in patients over 70 years of age. The hazard ratio was significantly increased as the number of involved risk factors was increased in patients who didn’t receive chemotherapy. Adding oxaliplatin showed no difference in survival (HR, 1.36; 95% CI, 0.91 to 2.03; p=0.132). CONCLUSION: Adjuvant chemotherapy can be recommended for stage II colon cancer patients, but the addition of oxaliplatin to the regimen must be selective.


Subject(s)
Humans , Adenocarcinoma , Chemotherapy, Adjuvant , Colon , Colonic Neoplasms , Drug Therapy , Follow-Up Studies , Lymph Nodes , Multivariate Analysis , Risk Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...